PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26255123-7 2015 Catalpol administration also further decreased BDNF activities, downregulated the mRNA expression of BDNF and tropomyosin-related kinase B (TrkB), and reversed the excessive elevation in the activities and mRNA expression levels of COX-2 and prostaglandin E2 (PGE2) in the hippocampus and frontal cortex of rats undergoing CUMS. catalpol 0-8 brain-derived neurotrophic factor Rattus norvegicus 47-51 26255123-7 2015 Catalpol administration also further decreased BDNF activities, downregulated the mRNA expression of BDNF and tropomyosin-related kinase B (TrkB), and reversed the excessive elevation in the activities and mRNA expression levels of COX-2 and prostaglandin E2 (PGE2) in the hippocampus and frontal cortex of rats undergoing CUMS. catalpol 0-8 brain-derived neurotrophic factor Rattus norvegicus 101-105 17078935-7 2006 The study also revealed a catalpol-associated increase of PKC and BDNF in the hippocampus of the catalpol-treated group in comparison with the aged rats and highly correlated with synaptophysin and GAP-43. catalpol 26-34 brain-derived neurotrophic factor Rattus norvegicus 66-70 31849446-0 2019 Catalpol Enhances Neurogenesis And Inhibits Apoptosis Of New Neurons Via BDNF, But Not The BDNF/Trkb Pathway. catalpol 0-8 brain-derived neurotrophic factor Rattus norvegicus 73-77 34332921-5 2021 Further real-time fluorescent quantitative polymerase chain reaction and Western blotting results together showed that CUMS significantly downregulated the expression levels of hippocampal genes and proteins, including PI3K, Akt, Nrf2, HO-1, tropomyosin-related kinase B (TrkB), and brain-derived neurotrophic factor; catalpol administration significantly reversed the abnormal expression of these genes and proteins. catalpol 318-326 brain-derived neurotrophic factor Rattus norvegicus 283-316 31545235-11 2019 Finally, western blot and immunostaining analysis suggested that several regulatory proteins involved in PFC development were up-regulated by catalpol treatment, such as brain-derived neurotrophic factor (BDNF), cyclin-dependent kinase 5 (Cdk5), p35, fibroblast growth factor (FGF) 21 and its receptor (FGFR)1. catalpol 142-150 brain-derived neurotrophic factor Rattus norvegicus 170-203 31545235-11 2019 Finally, western blot and immunostaining analysis suggested that several regulatory proteins involved in PFC development were up-regulated by catalpol treatment, such as brain-derived neurotrophic factor (BDNF), cyclin-dependent kinase 5 (Cdk5), p35, fibroblast growth factor (FGF) 21 and its receptor (FGFR)1. catalpol 142-150 brain-derived neurotrophic factor Rattus norvegicus 205-209